mutLBSgeneDB |
Gene summary for MST1R |
![]() |
Basic gene Info. | Gene symbol | MST1R |
Gene name | macrophage stimulating 1 receptor (c-met-related tyrosine kinase) | |
Synonyms | CD136|CDw136|PTK8|RON | |
Cytomap | UCSC genome browser: 3p21.3 | |
Type of gene | protein-coding | |
RefGenes | NM_001244937.1, NM_002447.2, | |
Description | MSP receptorMST1R variant RON30MST1R variant RON62PTK8 protein tyrosine kinase 8RON variant 21RON variant E2E3c-met-related tyrosine kinasemacrophage-stimulating protein receptorp185-Ronsoluble RON variant 1soluble RON variant 2soluble RON vari | |
Modification date | 20141222 | |
dbXrefs | MIM : 600168 | |
HGNC : HGNC | ||
Ensembl : ENSG00000164078 | ||
HPRD : 02545 | ||
Vega : OTTHUMG00000156709 | ||
Protein | UniProt: Q04912 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_MST1R | |
BioGPS: 4486 | ||
Pathway | NCI Pathway Interaction Database: MST1R | |
KEGG: MST1R | ||
REACTOME: MST1R | ||
Pathway Commons: MST1R | ||
Context | iHOP: MST1R | |
ligand binding site mutation search in PubMed: MST1R | ||
UCL Cancer Institute: MST1R | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID | GO:0009615 | response to virus | 12676986 | GO:0043406 | positive regulation of MAP kinase activity | 12676986 | GO:0051897 | positive regulation of protein kinase B signaling | 12676986 |
Top |
Ligand binding site mutations for MST1R |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | R1212 | T1212I | BLCA | 1 | V1096 | V1094M | LUAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for MST1R |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for MST1R |
![]() |
![]() |
Top |
Top |
Phenotype information for MST1R |
![]() |
Disease ID | Disease name | # PubMed | Association type |
umls:C0860207 | Drug-Induced Liver Injury | 1 | Biomarker |
umls:C0029463 | Osteosarcoma | 1 | Biomarker |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for MST1R |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | ANP | AMP-PNP | 3pls | A | V1096 R1212 |
Top |
Conservation information for LBS of MST1R |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |